Isolation of Nucleic Acids from Body Fluids

Handbook of Nucleic Acid Purification

Volumn , Issue , 2009, Pages 381-403

  Page, Karen ^a   Shaw, Jacqueline Amanda ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861740374     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420070972-26     Document Type: Chapter

References (127)

1. Mandel, P. and Métais, P., Les acides nucleiques du plasma sanguin l’homme, CR Acad. Sci. Paris, 142: 241, 1947.
2. Tan, E.M. et al., Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus, J. Clin. Invest., 45: 1732, 1966.
3. Leon, S.A. et al., Free DNA in the serum of cancer patients and the effect of therapy, Cancer Res., 37: 646, 1977.
4. Koffler, D. et al., The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases, J. Clin. Invest., 52: 198, 1973.
5. Leon, S.A. et al., DNA in synovial fluid and the circulation of patients with arthritis, Arthritis Rheum., 24: 1142, 1981.
6. Shapiro, B. et al., Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease, Cancer, 51: 2116, 1983.
7. Stroun, M. et al., Neoplastic characteristics of the DNA found in the plasma of cancer patients, Oncology, 46: 318, 1989.
8. Sorenson, G.D. et al., Soluble normal and mutated DNA sequences from single-copy genes in human blood, Cancer Epidemiol. Biomark. Prev., 3: 67, 1994.
9. Vasioukhin, V. et al., Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukemia, Br. J. Haematol., 86: 774, 1994.
10. Chen, X.Q. et al., Microsatellite alterations in plasma DNA of small cell lung cancer patients, Nat. Med., 2: 1033, 1996.
11. Nawroz, H. et al., Microsatellite alterations in serum DNA of head and neck cancer patients, Nat. Med., 2: 1035, 1996.
12. Esteller, M. et al., Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients, Cancer Res., 59: 67, 1999.
13. Wong, I.H. et al., Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients, Cancer Res., 59: 71, 1999.
14. Lo, Y.M. et al., Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma, Cancer Res., 59: 1188, 1999.
15. Herrera, L.J. et al., Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies, Clin. Chem., 51: 113, 2005.
16. Sai, S. et al., Quantification of plasma cell-free DNA in patients with gastric cancer, Anticancer Res., 27: 2747, 2007.
17. Taback, B. et al., Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients, Cancer Res., 61: 5723, 2001.
18. Vdovichenko, K.K., Markova, S.I., and Belokhvostov, A.S., Mutant form of BRAF gene in blood plasma of cancer patients, Ann. N. Y. Acad. Sci., 1022: 228, 2004.
19. de Kok, J.B. et al., Detection of tumor DNA in serum of colorectal cancer patients, Scand. J. Clin. Lab. Invest., 57: 601, 1997.
20. Kopreski, M.S. et al., Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer, Br. J. Cancer, 76: 1293, 1997.
21. Silva, J.M. et al., Presence of tumor DNA in plasma of breast cancer patients: Clinicopathological correlations, Cancer Res., 59: 3251, 1999.
22. Shaw, J.A. et al., Microsatellite alterations plasma DNA of primary breast cancer patients, Clin. Cancer Res., 6: 1119, 2000.
23. Silva, J.M. et al., TP53 gene mutations in plasma DNA of cancer patients, Genes Chromosom. Cancer, 24: 160, 1999.
24. Bruhn, N. et al., Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer, Ann. N. Y. Acad. Sci., 906: 72, 2000.
25. Goessl, C. et al., Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma, Cancer Res., 58: 4728, 1998.
26. Utting, M. et al., Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: A minimally invasive method for the detection of bladder cancer, Clin. Cancer Res., 8: 35, 2002.
27. Mulcahy, H.E. et al., A prospective study of K-ras mutations in the plasma of pancreatic cancer patients, Clin. Cancer Res., 4: 271, 1998.
28. Chang, H.W. et al., Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer, J. Natl. Cancer Inst., 94: 1697, 2002.
29. Kersemaekers, A.M. et al., Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix, Br. J. Cancer, 77: 192, 1998.
30. Goessl, C. et al., Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids, Cancer Res., 60: 5941, 2000.
31. Frickhofen, N. et al., Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia, Blood, 90: 4953, 1997.
32. Pathak, A.K., et al., Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool, Clin. Chem., 52: 1833, 2006.
33. Anker, P. et al., Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients, Cancer Metastasis Rev., 18: 65, 1999.
34. Jahr, S. et al., DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res., 61: 1659, 2001.
35. Anker, P., Stroun, M., and Maurice, P.A., Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system, Cancer Res., 35: 2375, 1975.
36. Diehl, F. et al., Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proc. Natl. Acad. Sci. U. S. A., 102: 16368, 2005.
37. Moss, T.J. and Sanders, D.G., Detection of neuroblastoma cells in blood, J. Clin. Oncol., 8: 736, 1990.
38. Foss, A.J. et al., The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction, Br. J. Cancer, 72: 155, 1995.
39. Mattano, L.A., Jr., Moss, T.J., and Emerson, S.G., Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction, Cancer Res., 52: 4701, 1992.
40. Chen, X. et al., Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer, Clin. Cancer Res., 5: 2297, 1999.
41. Frost, P.G. and Lachmann, P.J., The relationship of deoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies, Clin. Exp. Immunol., 3: 447, 1968.
42. Lo, Y.M. et al., Rapid clearance of fetal DNA from maternal plasma, Am. J. Hum. Genet., 64: 218, 1999.
43. Silva, J.M. et al., Persistence of tumor DNA in plasma of breast cancer patients after mastectomy, Ann. Surg. Oncol., 9: 71, 2002.
44. Page, K. et al., The importance of careful blood processing in isolation of cell-free DNA, Ann. N. Y. Acad. Sci., 1075: 313, 2006.
45. Wang, B.G. et al., Increased plasma DNA integrity in cancer patients, Cancer Res., 63: 3966, 2003.
46. Page, K., unpublished data, 2007.
47. Umetani, N. et al., Prediction of breast tumor progression by integrity of free circulating DNA in serum, J. Clin. Oncol., 24: 4270, 2006.
48. Umetani, N. et al., Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: Direct quantitative PCR for ALU repeats, Clin. Chem., 52: 1062, 2006.
49. von Knobloch, R. et al., Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis, Int. J. Cancer, 94: 67, 2001.
50. Berger, A.P. et al., Microsatellite alterations in human bladder cancer: Detection of tumor cells in urine sediment and tumor tissue, Eur. Urol., 41: 532, 2002.
51. Taback, B. et al., Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients, Cancer Res., 63: 1884, 2003.
52. Carstensen, T. et al., Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancer, Ann. N. Y. Acad. Sci., 1022: 202, 2004.
53. Schmidt, B. et al., Quantification of free RNA in serum and bronchial lavage: A new diagnostic tool in lung cancer detection?, Lung Cancer, 48: 145, 2005.
54. Belinsky, S.A. et al., Gene promoter methylation in plasma and sputum increases with lung cancer risk, Clin. Cancer Res., 11: 6505, 2005.
55. Mao, L. et al., Molecular detection of primary bladder cancer by microsatellite analysis, Science, 271: 659, 1996.
56. Steiner, G. et al., Detection of bladder cancer recurrence by microsatellite analysis of urine, Nat. Med., 3: 621, 1997.
57. Su, Y.H. et al., Detection of a K-ras mutation in urine of patients with colorectal cancer, Cancer Biomark., 1: 177, 2005.
58. Miyake, M. et al., Sensitive detection of FGFR3 mutations in bladder cancer and urine sediments by peptide nucleic acid-mediated real-time PCR clamping, Biochem. Biophys. Res. Commun., 362: 865, 2007.
59. Szarvas, T. et al., Deletion analysis of tumor and urinary DNA to detect bladder cancer: Urine supernatant versus urine sediment, Oncol. Rep., 18: 405, 2007.
60. Majer, S. et al., Maternal urine for prenatal diagnosis-An analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester, Prenat. Diagn., 27: 1219, 2007.
61. Schwarzenbach, H. et al., Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer, Int. J. Cancer., 120: 1465, 2007.
62. Wang, Y.C. et al., Molecular diagnostic markers for lung cancer in sputum and plasma, Ann. N. Y. Acad. Sci., 1075: 179, 2006.
63. Kopreski, M.S. et al., Detection of tumor messenger RNA in the serum of patients with malignant melanoma, Clin. Cancer Res., 5: 1961, 1999.
64. Novakovic, S. et al., Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer, Oncol. Rep., 11: 245, 2004.
65. Miura, N. et al., Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma, Oncology, 64: 430, 2003.
66. Guin, L.W. et al., Electrophoretic characterization of plasma RNA, Biochem. Med., 13: 224, 1975.
67. Lo, K.W. et al., Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma, Clin. Chem., 45: 1292, 1999.
68. Ng, E.K. et al., The concentration of circulating corticotrophin-releasing hormone mRNA in maternal plasma is increased in pre-eclampsia, Clin. Chem., 49: 727, 2003.
69. Tsui, N.B., Ng, E.K., and Lo, Y.M., Stability of endogenous and added RNA in blood specimens, serum, and plasma, Clin. Chem., 48: 1647, 2002.
70. Tong, Y.K. and Lo, Y.M., Diagnostic developments involving cell-free (circulating) nucleic acids, Clin. Chim. Acta, 363: 187, 2006.
71. Silva, J.M. et al., Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics, Clin. Cancer Res., 7: 2821, 2001.
72. Chen, X.Q. et al., Telomerase RNA as a detection marker in the serum of breast cancer patients, Clin. Cancer Res., 6: 3823, 2000.
73. Wong, B.C. et al., Reduced plasma RNA integrity in nasopharyngeal carcinoma patients, Clin. Cancer Res., 12: 2512, 2006.
74. Juusola, J. and Ballantyne, J., Multiplex mRNA profiling for the identification of body fluids, Forensic Sci. Int., 152: 1, 2005.
75. Juusola, J. and Ballantyne, J., mRNA profiling for body fluid identification by multiplex quantitative RT-PCR, J. Forensic Sci., 52: 1252, 2007.
76. El-Hefnawy, T. et al., Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics, Clin. Chem., 50: 564, 2004.
77. Garcia, J.M. et al., Extracellular tumor DNA in plasma and overall survival in breast cancer patients, Genes Chromosom. Cancer, 45: 692, 2006.
78. Lo, Y.M. et al., Plasma DNA as a prognostic marker in trauma patients, Clin. Chem., 46: 319, 2000.
79. Rainer, T.H. et al., Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke, Clin. Chem., 49: 562, 2003.
80. Tsang, J.C. and Lo, Y.M., Circulating nucleic acids in plasma/serum, Pathology, 39: 197, 2007.
81. Lo, Y.M. et al., Presence of fetal DNA in maternal plasma and serum, Lancet, 350: 485, 1997.
82. Lo, Y.M. et al., Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis, Am. J. Hum. Genet., 62: 768, 1998.
83. Costa, J.M., Benachi, A., and Gautier, E., New strategy for prenatal diagnosis of X-linked disorders, N. Engl. J. Med., 346: 1502, 2002.
84. Lo, Y.M. et al., Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N. Engl. J. Med., 339: 1734, 1998.
85. Chiu, R.W. et al., Prenatal exclusion of beta thalassemia major by examination of maternal plasma, Lancet, 360: 998, 2002.
86. Lo, Y.M. et al., Quantitative abnormalities of fetal DNA in maternal serum in pre-eclampsia, Clin. Chem., 45: 184, 1999.
87. Lo, Y.M. et al., Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21, Clin. Chem., 45: 1747, 1999.
88. Leon, S.A. et al., Radioimmunoassay for nanogram quantities of DNA, J. Immunol. Methods, 9: 157, 1975.
89. Lee, T.H. et al., Quantitation of genomic DNA in plasma and serum samples: Higher concentrations of genomic DNA found in serum than in plasma, Transfusion, 41: 276, 2001.
90. Taback, B., O’Day, S.J., and Hoon, D.S., Quantification of circulating DNA in the plasma and serum of cancer patients, Ann. N. Y. Acad. Sci., 1022: 17, 2004.
91. Thijssen, M.A. et al., Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases, Anticancer Res., 22: 421, 2002.
92. Umetani, N., Hiramatsu, S., and Hoon, D.S., Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation, Ann. N. Y. Acad. Sci., 1075: 299, 2006.
93. Jung, M. et al., Changes in concentration of DNA in serum and plasma during storage of blood samples, Clin. Chem., 49: 1028, 2003.
94. Lam, N.Y. et al., EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis, Clin. Chem., 50: 256, 2004.
95. Chiu, R.W., et al., Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma, Clin. Chem., 47: 1607, 2001.
96. Schmidt, B. et al., Detection of cell-free nucleic acids in bronchial lavage fluid supernatants from patients with lung cancer, Eur. J. Cancer, 40: 452, 2004.
97. Miller, S.A., Dykes, D.D., and Polesky, H.F., A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res., 16: 1215, 1988.
98. Schmidt, B. et al., Improved method for isolating cell-free DNA, Clin. Chem., 51: 1561, 2005.
99. Su, Y.H. et al., Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer, J. Mol. Diagn., 6: 101, 2004.
100. Greenspoon, S.A. et al., QIAamp spin columns as a method of DNA isolation for forensic casework, J. Forensic Sci., 43: 1024, 1998.
101. Johns, M.B., Jr. and Paulus-Thomas, J.E., Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol, Anal. Biochem., 180: 276, 1989.
102. Boom, R. et al., Rapid and simple method for purification of nucleic acids, J. Clin. Microbiol., 28: 495, 1990.
103. Jen, J., Wu, L., and Sidransky, D., An overview on the isolation and analysis of circulating tumor DNA in plasma and serum, Ann. N. Y. Acad. Sci., 906: 8, 2000.
104. Kephart, D.K.S., Grunst, T., and Shenoi, H., Introducing the Maxwell 16 instrument: A simple, robust and flexible tool for DNA purification, Promega Notes, 20, 2006.
105. Allen, D. et al., Role of cell-free plasma DNA as a diagnostic marker for prostate cancer, Ann. N. Y. Acad. Sci., 102: 276, 2004.
106. Gal, S. et al., Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR, Br. J. Cancer, 90: 1211, 2004.
107. de Kok, J.B. et al., Use of real-time quantitative PCR to compare DNA isolation methods, Clin. Chem., 44: 2201, 1998.
108. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162: 156, 1987.
109. Tamkovich, S.N. et al., Simple and rapid procedure suitable for quantitative isolation of low and high molecular weight extracellular nucleic acids, Nucleos. Nucleot. Nucleic Acids, 23: 873, 2004.
110. Cerkovnik, P. et al., Optimization of an RNA isolation procedure from plasma samples, Int. J. Mol. Med., 20: 293, 2007.
111. Xie, G.S. et al., Quantification of plasma DNA as a screening tool for lung cancer, Chin. Med. J. (Engl), 117: 1485, 2004.
112. Tamkovich, S.N. et al., Circulating DNA and DNase activity in human blood, Ann. N. Y. Acad. Sci., 1075: 191, 2006.
113. Bearzatto, A. et al., p16 (INK4A) hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer, Clin. Cancer Res., 8: 3782, 2002.
114. Silva, J.M. et al., Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival, Clin. Cancer Res., 8: 3761, 2002.
115. Kamm, R.C. and Smith, A.G., Nucleic acid concentrations in normal human plasma, Clin. Chem., 18: 519, 1972.
116. Sozzi, G. et al., Quantification of free circulating DNA as a diagnostic marker in lung cancer, J. Clin. Oncol., 21: 3902, 2003.
117. Huang, Z.H., Li, L.H., and Hua, D., Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients, Cancer Lett., 243: 64, 2006.
118. Zhong, X.Y. et al., Elevated level of cell-free plasma DNA is associated with breast cancer, Arch. Gynecol. Obstet., 276: 327, 2007.
119. Lledó, S.M. et al., Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer, Colorectal Dis., 6: 236, 2004.
120. Chomczynski, P. and Sacchi, N., The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: Twenty-something years on, Nat. Prot., 1: 581, 2006.
121. Gormally, E. et al., Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance, Mutat. Res., 635: 105, 2007.
122. Quackenbush, J., Microarray analysis and tumor classification, N. Engl. J. Med., 354: 2463, 2006.
123. Sung, F.L. et al., Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma, Cancer Lett., 253: 74, 2007.
124. Nakamura, N. et al., Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients, DNA Res., 13: 169, 2006.
125. Tsui, N.B. et al., Systematic micro-array based identification of placental mRNA in maternal plasma: Towards non-invasive prenatal gene expression profiling, J. Med. Genet., 41: 461, 2004.
126. Li, Y. et al., Salivary transcriptome diagnostics for oral cancer detection, Clin. Cancer Res., 10: 8442, 2004.
127. Sozzi, G. et al., Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients, Cancer Res., 61: 4675, 2001.